Mesoporous Silicon (PSi) for Sustained Peptide Delivery: Effect of PSi Microparticle Surface Chemistry on Peptide YY3-36 Release

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Pharmaceutical Research

• Publication date

  2012-03-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1007/s11095-011-0611-6PMID 22033881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Agarose Surface Coating Influences Intracellular Accumulation and Enhances Payload Stability of a Nano-delivery System

  2011cited by this paper
• Reversibility of the adsorption of lysozyme on silica.

  2011cited by this paper
• Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery.

  2011cited by this paper
• Structural dynamics of neuropeptide hPYY.

  2011cited by this paper
• Issues in long-term protein delivery using biodegradable microparticles.

  2010cited by this paper
• Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats.

  2010cited by this paper
• Thermal oxidation for controlling protein interactions with porous silicon.

  2010cited by this paper
• Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation.

  2010influential reference
• Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs.

  2010cited by this paper
• In vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice.

  2010cited by this paper
• The role of gut hormones in the regulation of body weight and energy homeostasis.

  2010cited by this paper
• The role of peptide YY in appetite regulation and obesity

  2009cited by this paper
• In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles.

  2009cited by this paper
• Biodegradable luminescent porous silicon nanoparticles for in vivo applications.

  2009cited by this paper
• Pharmaceutical Formulation Development Of Peptides And Proteins

  2009cited by this paper
• Mesoporous silicon in drug delivery applications.

  2008cited by this paper
• Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles.

  2008cited by this paper
• Peptide YY

  2008cited by this paper
• Pharmacokinetics and Pharmacodynamic Effects of Oral GLP‐1 and PYY3‐36: A Proof‐of‐concept Study in Healthy Subjects

  2008cited by this paper
• Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans.

  2008cited by this paper
• Peptide and protein loading into porous silicon wafers

  2008cited by this paper
• Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles.

  2007cited by this paper
• Enhanced in vitro permeation of furosemide loaded into thermally carbonized mesoporous silicon (TCPSi) microparticles.

  2007cited by this paper
• Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults.

  2007cited by this paper
• Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.

  2007cited by this paper
• Loading and release of a model protein from porous silicon powders

  2007cited by this paper
• Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats.

  2006cited by this paper
• Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs.

  2005cited by this paper
• Reversible PEGylation of peptide YY3‐36 prolongs its inhibition of food intake in mice

  2005cited by this paper
• Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques.

  2005cited by this paper
• Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.

  2005cited by this paper
• Protein drug stability: a formulation challenge

  2005cited by this paper
• Use of thermoanalytical methods in quantification of drug load in mesoporous silicon microparticles

  2005cited by this paper
• Stabilization of porous silicon surface by thermal decomposition of acetylene

  2004cited by this paper
• Microfabricated Porous Silicon Particles Enhance Paracellular Delivery of Insulin Across Intestinal Caco-2 Cell Monolayers

  2004cited by this paper
• Characterization of Blood-Brain Barrier Permeability to PYY3-36 in the Mouse

  2003cited by this paper
• Inhibition of food intake in obese subjects by peptide YY3-36.

  2003cited by this paper
• Penetration and loading of human serum albumin in porous silicon layers with different pore sizes and thicknesses.

  2003cited by this paper
• Characterization of Nanoporous Membranes for Immunoisolation: Diffusion Properties and Tissue Effects

  2002cited by this paper
• Thermal Hydrosilylation of Undecylenic Acid with Porous Silicon

  2002cited by this paper
• Gut hormone PYY3-36 physiologically inhibits food intake

  2002cited by this paper
• Structure and dynamics of membrane proteins as studied by infrared spectroscopy.

  1999cited by this paper
• Pharmacokinetics tricks and traps: flip-flop models.

  1998cited by this paper
• Peptide degradation during preparation and in vitro release testing of poly(l-lactic acid) and poly(dl-lactic-co-glycolic acid) microparticles

  1998cited by this paper
• Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides

  1980cited by this paper
• The Determination of Pore Volume and Area Distributions in Porous Substances. II. Comparison between Nitrogen Isotherm and Mercury Porosimeter Methods

  1951cited by this paper
• (CONTRIBUTION FROM THE MULTIPLE FELLOWSHIP OF BAUGH AND SONS COMPANY, MELLOX INSTITUTE) The Determination of Pore Volume and Area Distributions in Porous Substances. I. Computations from Nitrogen Isotherms

  1951cited by this paper
• ADSORPTION OF GASES IN MULTIMOLECULAR LAYERS

  1938cited by this paper

• Unveiling the Arsenal against Antibiotic Resistance: Antibacterial Peptides as Broad-Spectrum Weapons Targeting Multidrug-Resistant Bacteria

  2024cites this paper
• Porous silicon and silica carriers for delivery of peptide therapeutics

  2024cites this paper
• Porous Silicon Microparticles Enable Sustained Release of GLP‐1R Agonist Peptides for the Treatment of Type 2 Diabetes

  2024cites this paper
• Dual-Drug Delivery by Anisotropic and Uniform Hybrid Nanostructures: A Comparative Study of the Function and Substrate–Drug Interaction Properties

  2023cites this paper
• Recent Advances in Formulations for Long-Acting Delivery of Therapeutic Peptides.

  2023cites this paper
• Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis

  2021cites this paper
• Thermal stabilization of porous silicon

  2021cites this paper
• Opportunities and Challenges of Silicon‐based Nanoparticles for Drug Delivery and Imaging

  2021cites this paper
• Hybrid red blood cell membrane coated porous silicon nanoparticles functionalized with cancer antigen induce depletion of T cells

  2020cites this paper
• Enteric Polymer-Coated Porous Silicon Nanoparticles for Site-Specific Oral Delivery of IgA Antibody.

  2020cites this paper
• Porous silicon nanomaterials: recent advances in surface engineering for controlled drug-delivery applications.

  2019cites this paper
• Automatic methodologies to perform loading and release assays of anticancer drugs from mesoporous silicon nanoparticles.

  2019cites this paper
• Improvements in chemical carriers of proteins and peptides

  2019cites this paper
• Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke.

  2019cites this paper
• pH-Responsive Nanofibers for Precise and Sequential Delivery of Multiple Payloads.

  2019cites this paper
• Biohybrid Cloaked Nanovaccines For Cancer Immunotherapy

  2019cites this paper
• Photoluminescent and biodegradable porous silicon nanoparticles for biomedical imaging.

  2019cites this paper
• Thermally Carbonized Porous Silicon and Its Recent Applications

  2018cites this paper
• Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy

  2018cites this paper
• Biocompatibility of porous silicon

  2018cites this paper
• Biodegradation of inorganic drug delivery systems in subcutaneous conditions

  2018cites this paper
• Development of automatic systems to study the loading and release of anticancer drugs from mesoporous silica nanoparticles

  2018cites this paper
• Design and pharmaceutical applications of porous particles

  2017cites this paper
• A multifunctional nanocomplex for enhanced cell uptake, endosomal escape and improved cancer therapeutic effect.

  2017cites this paper
• Glucagon-like peptide-1 and glucagon-like peptide-1 analogs nanotechnology-based systems for prevention and therapy of diabetes

  2017cites this paper
• Sequence-Controlled Delivery of Peptides from Hierarchically Structured Nanomaterials.

  2017cites this paper
• Applications of Monolayer-Functionalized H-Terminated Silicon Surfaces: A Review

  2017cites this paper
• Multifunctional Nanoparticles for Targeted Drug Delivery and Imaging for Ischemic Myocardial Injury

  2017cites this paper
• Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling.

  2017cites this paper
• Biomolecule Attachment to Porous Silicon

  2016cites this paper
• The potential of porous silicon particles for multi-epitopic vaccine development

  2016cites this paper
• Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model.

  2016cites this paper
• Influence of Surface Chemistry on Ibuprofen Adsorption and Confinement in Mesoporous Silicon Microparticles.

  2016cites this paper
• Multi-Approach Design and Fabrication of Hybrid Composites for Drug Delivery and Cancer Therapy

  2016cites this paper
• Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery.

  2016cites this paper
• Thiolation and Cell‐Penetrating Peptide Surface Functionalization of Porous Silicon Nanoparticles for Oral Delivery of Insulin

  2016cites this paper
• Prasanna Sakha Development of Microfluidic Applications to Study the Role of Kainate Receptors in Synaptogenesis

  2016influential citation
• Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: A controlled dual protein-drug delivery system.

  2015cites this paper
• Novel Delivery Systems for Improving the Clinical Use of Peptides

  2015influential citation
• Mechanism of erosion of nanostructured porous silicon drug carriers in neoplastic tissues

  2015cites this paper
• Chemical surface modification of porous silicon nanoparticles for cancer therapy

  2015cites this paper
• Delivery Systems for Biopharmaceuticals. Part I: Nanoparticles and Microparticles.

  2015cites this paper
• Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.

  2015cites this paper
• Effect of Surface Chemistry on the Immune Responses and Cellular Interactions of Porous Silicon Nanoparticles

  2015cites this paper
• Memristive devices from porous silicon – ZnO/VO2 nanocomposites

  2015cites this paper
• Inorganic Nanoparticles in Targeted Drug Delivery and Imaging

  2015cites this paper
• Use of Porous Silicon for In Vivo Imaging Techniques

  2015cites this paper
• Functionalization of alkyne-terminated thermally hydrocarbonized porous silicon nanoparticles with targeting peptides and antifouling polymers: effect on the human plasma protein adsorption.

  2015cites this paper
• Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides.

  2014cites this paper
• Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications.

  2014cites this paper
• Facile synthesis of biocompatible superparamagnetic mesoporous nanoparticles for imageable drug delivery

  2014cites this paper
• Porous Silicon-Based Multicomposites for Controlled Drug Delivery

  2014influential citation
• Confinement effects on drugs in thermally hydrocarbonized porous silicon.

  2014cites this paper
• Drug Delivery with Porous Silicon

  2014cites this paper
• The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium.

  2014cites this paper
• Antihyperglycemic potential of incretins orally delivered via nano and microsystems and subsequent glucoregulatory effects.

  2014cites this paper
• Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers.

  2014influential citation
• Thermal stabilization of porous silicon for biomedical applications

  2014cites this paper
• DRUG LOADING AND RELEASE PROPERTIES OF MESOPOROUS SILICON NANOPARTICLES USING D-LUCIFERIN AS A DRUG-LIKE MODEL MOLECULE

  2014influential citation
• Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors.

  2014cites this paper
• Porous silicon functionalities for BioMEMS

  2014cites this paper
• Biocompatibility of porous silicon for biomedical applications

  2014cites this paper
• Silicon-Based Nanoagents for Cancer Therapy

  2014cites this paper
• CHEMICAL AND BIOCHEMICAL MODIFICATION OF MESOPOROUS SILICON FOR IN VIVO ANALYSIS

  2013cites this paper
• Porous silicon for drug delivery

  2013cites this paper
• Porous Silicon Nanoparticles

  2013cites this paper
• Designing porous silicon-based microparticles as carriers for controlled delivery of mitoxantrone dihydrochloride

  2013cites this paper
• Development of porous silicon nanocarriers for parenteral peptide delivery.

  2013cites this paper
• Recent advances in porous silicon technology for drug delivery.

  2013cites this paper
• Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity.

  2013cites this paper
• Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride.

  2013cites this paper
• Inhibition of influenza A virus infection in vitro by saliphenylhalamide-loaded porous silicon nanoparticles.

  2013cites this paper
• Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles.

  2013cites this paper
• Celecoxib confinement within mesoporous silicon for enhanced oral bioavailability

  2013cites this paper
• Functionalization of mesoporous silicon nanoparticles for targeting and bioimaging purposes

  2012cites this paper
• Thermally promoted addition of undecylenic acid on thermally hydrocarbonized porous silicon optical reflectors

  2012cites this paper
• Surface chemistry of porous silicon and implications for drug encapsulation and delivery applications.

  2012cites this paper
• Amine modification of thermally carbonized porous silicon with silane coupling chemistry.

  2012cites this paper
• Porous silicon micro- and nanoparticles for printed humidity sensors

  2012cites this paper
• Biocompatibility and biofunctionalization of mesoporous silicon particles

  2012cites this paper
• Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations.

  2012cites this paper
• LAYER-BY-LAYER ASSEMBLY OF THE POLYELECTROLYTES ON MESOPOROUS SILICON NANOPARTICLES

  2012influential citation